FIELD: medicine.
SUBSTANCE: knee joint injury is simulated in rats by 5 intra-articular administrations of the antioxidant ethoxydol 5 mg/kg every second day.
EFFECT: invention enables reducing doses or withdrawing non-steroidal anti-inflammatory preparations and glucocorticoids, and enables reducing the activity of destructive processes in the involved injury that leads to reducing the activity of progressive posttraumatic osteoarthrosis in the initial stage.
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT POSSESSING ANTI-INFLAMMATORY, ANTIOXIDANT AND ANTIULCEROGENIC ACTION, ABILITY TO INHIBIT DEVELOPMENT OF DEGENERATIVE-DESTRUCTIVE PROCESSES OF TISSUES, WHICH IS 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINIUM-4-ISOBUTYLPHENYLPROPANOATE | 2023 |
|
RU2814495C1 |
| METHOD OF ESTIMATING INTENSITY OF DESTRUCTIVE PROCESSES IN CASE OF KNEE JOINT TRAUMATIC INJURY AND PREDICTION OF DEVELOPMENT OF POST-TRAUMATIC ARTHROSIS | 2011 |
|
RU2463000C1 |
| METHOD FOR PROPHYLAXIS OF POSTTRAUMATIC OSTEOARTHROSIS | 2004 |
|
RU2271816C1 |
| METHOD OF TREATING POSTTRAUMATIC KNEE ARTHRITIS | 2011 |
|
RU2456988C1 |
| COMBINED AGENT FOR INTRAARTICULAR ADMINISTRATION | 2017 |
|
RU2737380C2 |
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS, OSTEOPOROSIS AND OSTEOARTHROSIS | 2013 |
|
RU2521227C1 |
| METHOD FOR PREVENTING AND TREATING ARTHROPATHIES AND METHODS FOR USING SAME | 2013 |
|
RU2521973C1 |
| COMPOSITION FOR TREATING AND PREVENTING OSTEOARTHRITIS AND OSTEOARTHROSIS | 2011 |
|
RU2509569C2 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739746C1 |
| METHOD OF INTRA-ARTICULAR TREATMENT OF ANTIGEN-INDUCED ARTHRITIS | 2007 |
|
RU2341268C1 |
Authors
Dates
2014-05-20—Published
2013-03-01—Filed